Who
Marla L. Kessler
Director
Company insider
Files Form 4 as: Director, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $200K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 1 Apr 2019
- Last trade
- 16 Jun 2026
- Last filed
- 17 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 16 Jun 2026filed 17 Jun 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —63,481 at $0.00 | filing |
| 10 Jun 2025filed 12 Jun 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 18 Jun 2024filed 21 Jun 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —24,311 at $0.00 | filing |
| 14 Dec 2023filed 18 Dec 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $111K9,926 at $11.19 | filing |
| 20 Jun 2023filed 22 Jun 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,350 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $89K7,610 at $11.65 | filing |
| 1 Jun 2022filed 3 Jun 2022 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,571 at $0.00 | filing |
| 2 Jun 2021filed 4 Jun 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,766 at $0.00 | filing |
| 3 Jun 2020filed 5 Jun 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —21,720 at $0.00 | filing |
| 29 May 2019filed 31 May 2019 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —22,706 at $0.00 | filing |
| 1 Apr 2019filed 3 Apr 2019 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —2,995 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.